Matches 1 - 50 out of 224 1 2 3 4 5 >
Match Document Document Title
7615546 Topical delivery system for phytosterols  
This invention relates to certain sugar esters of phytosterols of formula (I). These esters are useful for topical application, and for the treatment of skin condition, including age spots, acne,...
7601706 Bile-acid conjugates providing for sustained systemic concentration of drugs  
This invention is directed to compounds that provide for sustained systemic concentrations of therapeutic or prophylactic agents following administration to animals. This invention is also directed...
7592329 Crystalline complexes of fluticasone-2-furoate  
There is provided a crystalline complex comprising a compound of formula (I) in which the crystal lattice is stabilized by the presence of a guest molecule, characterized in that the...
7576055 Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier  
This invention relates to a highly efficient artificial low-density lipoprotein (LDL) carrier system for the targeted delivery therapeutic agents across the blood-brain barrier (BBB). In...
7563565 Method of preparing bio-identical hormones  
The embodied composition is a dose of bio-identical hormones in a solvent with a vasodilator, a hormone modulator, and a carrier for balancing and maintaining Cortisol level in a human. The dose...
7544674 Topical skin care composition  
A cream base for the topical application of skin care therapeutics and a process for making the cream base. In one embodiment, the therapeutic is tretinoin, hydroquinone and fluocinolone acetonide...
7541350 Formulation containing anti-inflammatory androstane derivative  
There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) or a solvate thereof.
7531528 Formulation containing anti-inflammatory androstane derivatives  
There is provided according to the invention a pharmaceutical formulation comprising an aqueous carrier liquid having dissolved therein (a) an ester of fluticasone or a solvate thereof as...
7507720 5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia  
The invention discloses the use of sapogenin derivatives in the treatment of cognitive disfunction and similar conditions. Methods of treatment and pharmaceutical compositions are also disclosed.
7498321 17β-carbothioate 17α-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents  
There are provided according to the invention compounds of formula (I) wherein R 1 represents C 1-6 alkyl or C 1-6 haloalkyl; R 2 represents —C(═O)-aryl or —C(═O)-heteroaryl; R 3 ...
7488722 Anxiolytic Marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods  
Pharmaceutical compositions for preventing or treating anxiety, comprising betulinic acid or derivatives thereof are provided. Methods for preventing or treating anxiety with betulinic acid or...
7405206 Anti-inflammatory androstane derivatives  
There are provided compounds of formula (I) wherein R 1 represents O, S or NH; R 2 represents —C(═O)-aryl or —C(═O)-heteroaryl; R 3 represents hydrogen, methyl (which may be in...
7335349 Fish attractants  
The present invention provides a fish attracting composition. Previously fish sex hormones were considered only to have a role in sexual reproduction, however the present invention shows that these...
7312207 Topical steroid cream formulations  
Disclosed is a novel mometasone furoate cream formulation for topical administration in a oleaginous base containing propylene glycol. This cream is a cosmetically elegant preparation of mometasone...
7112580 3-nitrogen-6, 7-dioxygen steroids and uses related thereto  
A compound of the formula: and pharmaceutically acceptable salts, solvates, stereoisomers and prodrugs thereof, in isolation or in mixture, wherein R groups are as defined by the present...
7108867 Process for preparing particles  
A process for preparing particles of a substance, such as a protein or polypeptide, comprising: (a) preparing a first liquid comprising water, the substance and a modulator, wherein the modulator...
7101866 Anti-inflammatory androstane derivative  
According to one aspect of the invention, there is provided a compound of formula (I) and solvates thereof. There are also provided compositions containing the compound, processes for...
7087590 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them  
A 19-norbufalin derivative compound of formula (I): wherein the R groups are as defined by the present specification. The compounds are Na + K − -ATPase inhibitors and can be used in the...
7053076 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs  
Disclosed are compounds that exhibit high transport across the intestinal wall of an animal. The compounds may optionally be linked to drugs that are poorly absorbed or poorly transported across...
7049305 Bile-acid conjugates providing for sustained systemic concentration of drugs  
This invention is directed to compounds that provide for sustained systemic concentrations of therapeutic or prophylactic agents following administration to animals. This invention is also directed...
7037548 Soybean embryo fat/oil and process for producing soybean material with high embryo concentration  
The purpose of the present invention is to extract oil from the soybean material containing soybean germ as a main component, and to utilize it. The present invention relates to a method for...
7015210 Methods of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists  
A method for treating or preventing ophthalmic disorders comprising the administration of one or more aldosterone receptor antagonists that contain a 9,11-epoxy moiety, such as eplerenone is...
6956030 Use of mometasone furoate for treating upper airway diseases  
The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of...
6953785 Estra-1,3,5(10)-triene derivatives  
Provided is steroid sulfatase inhibitors comprising, as the active ingredient, an estra-1,3,5(10)-triene derivative which is represented by formula (I): {wherein R 1 and R 2 are the same or...
6949532 Use of mometasone furoate for treating airway passage and lung diseases  
The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of...
6930125 Airway alkalinization as a therapy for airway diseases  
The present invention relates to a method of treating asthma by raising the pH of the airways of an individual. The effect can be mediated directly by administering a pharmaceutically acceptable...
6921757 Organic compounds  
Compounds of formula (I), where R is a monovalent cyclic organic group having from 3 to 15 atoms in the ring system, useful as pharmaceuticals
6887861 Compounds for intracellular delivery of therapeutic moieties to nerve cells  
A method for improving intracellular administration of a therapeutic agent is provided comprising: contacting cells with a compound comprising a charged derivative of a therapeutic agent having a...
6878699 Taccalonolide microtubule stabilizing agents  
In accordance with the present invention, there have been identified extracts from a tropical plant that initiate paclitaxel-like microtubule bundling. Bioassay-directed purification yields the...
6875758 Method of treating hyperlipidemic and hyperglycemic conditions in mammals using pregnadienols and pregnadienones  
The invention provides a method of using pregnadienones and pregnadienols represented by the structural formula (I) as shown herein below Wherein X═OH or O or combination thereof and...
6803030 Bile acids conjugates with metal ion chelates and the use thereof  
Compounds able to chelate paramagnetic metal ions and the use thereof as contrast agents in the technique known as “Magnetic Resonance Imaging” (M.R.I.).
6780855 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS THAT CONTAIN THESE 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES AS WELL AS THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS  
This invention describes the new 11β-halogen-7α-substituted estratrienes of general formula I in which R 11 is a fluorine or chlorine atom, and the other substituents have the meanings that...
6777200 Kinesin motor modulators derived from the marine sponge Adocia  
This invention provides novel compounds derived from a marine sponge, Adocia sp., that specifically modulat kinesin activity by targeting the kinesin motor domain and mimicking the activity a...
6767901 Ciclesonide contained pharmaceutical composition for application to mucosa  
The present invention provides a pharmaceutical composition for application to the mucosa to be used in drug therapy comprising a water-insoluble and/or water-low soluble substance, ciclesonide,...
6759399 Use of antimineralocorticoid compounds against narcotic withdrawal syndrome  
The method of treating narcotic withdrawal symptoms in warm-blooded animals comprising administering to warm-blooded animals in need thereof an amount of a compound having anti-mineralocorticoid...
6759398 Anti-inflammatory androstane derivative  
According to one aspect of the invention, there is provided a pharmaceutical formulation for administration by inhalation comprising a compound of formula (I), or a solvate thereof, together...
6743414 Inhalation administration of biophosphonates  
The present invention relates to the treatment and prevention of bone diseases in humans, including osteoporosis in postmenopausal women, Paget's Disease and hypercalcemia, by administration of a...
6716437 Topical composition and method for enhancing lipid barrier synthesis  
The present invention relates to topical compositions useful in enhancing lipid synthesis in skin comprising an effective amount of cafestol or kahweol, or derivative thereof, in combination with a...
6696432 Combination of dehydroepiandrosterone and aromatase inhibitors and use of this combination to produce a medicament for treating relative and absolute androgen deficiency in men  
The present invention concerns the combination of dehydroepiandrosterone (DHEA) and at least one aromatase inhibitor and the use of such a combination to produce a medicament for treating relative...
6680310 Methods for preventing antipsychotic-induced weight gain  
This invention generally pertains to the field of psychiatry. In particular, this invention pertains to the discovery that agents capable of inhibiting the binding of cortisol to its receptors can...
6641800 Pressurized aerosol compositions comprising powdered medicament dispersed in hydrofluoroalkane  
Pressurized aerosol composition for administration by inhalation comprising a liquefied hydrofluoroalkane, a powdered medicament dispersed therein, and a suspending agent comprising a polymer...
6583129 Administration of non-oral androgenic steroids to women  
The present invention provides compositions, methods, and kits for improving health in a woman having elevated SHBG levels, or who is receiving oral estrogen supplementation, by non-orally...
6531461 Medicament for the treatment of diabetes  
A series of compounds of general structure I and metal salts thereof. These compounds are useful in the treatment of diabetes mellitus and associated conditions when administered in an effective...
6500815 Substituted 11.beta steroid derivatives, method for preparing same and intermediates of said method, use as medicine and compositions containing them  
The invention concerns compounds of formula (I) wherein: X, Y, R 1 , R 2 , Z, G are as defined in the description, the methods for preparing them and the intermediates in said method, their use as...
6488937 Allergy treatment method using a rapid immunotherapy protocol  
A method of treating a patient sensitive to an allergen includes a desensitizing rapid immunotherapy protocol of administering to the patient a series of gradually increasing doses of a composition...
6468994 Budesonide particles and pharmaceutical compositions containing them  
The invention provides finely divided, substantially crystalline particles of budesonide characterized in that they are substantially smooth and having a BET value of from 1 to 4.5 m2/g, a process...
6342490 Pharmaceutical composition containing uscharidin or its analogues  
The invention provides compositions comprising uscharin and the use of uscharin to combat cell proliferation for example in the treatment of cancer. Administration of uscharin may kill or reduce...
6306845 Method for treating demyelinating disease  
The present invention provides a method for treating a demyelinating disease in a subject which includes administering to the subject a therapeutically effective amount of a high affinity...
6297227 Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines  
The present invention discloses antibiotic-excluded compositions and methods to treat non-infective sinusitis and otitis media. The compositions comprise a therapeutically effective amount of a...
6288041 Sialic acid derivatives  
Sialic acid derivatives represented by the following general formula: ##STR1## wherein R 1 represents a residue of a steroid compound excluding cholestane and cholestene residues, R 2 represents...
Matches 1 - 50 out of 224 1 2 3 4 5 >